Comprehensive and Practical Brachytherapy March 04-8 March 2018, Ljubljana, Slovenia Day 1 Sunday 4 March 2018

Similar documents
INTRODUCTION TO BRACHYTHERAPY, HISTORY AND INDICATIONS. Christine Haie-Meder Brachytherapy Unit

Course Directors: Teaching Staff: Guest Lecturers: Local Organiser: ESTRO coordinator: Melissa Vanderijst, project manager (BE)

Course Directors: Teaching Staff: Guest Lecturers: Local Organiser: ESTRO coordinator: Melissa Vanderijst, project manager (BE)

Course Directors : Teaching Staff : Guest Lecturer: Local Organiser: ESTRO coordinators: Melissa Vanderijst and Marta Jayes, project managers (BEL)

Definitions. Brachytherapy in treatment of cancer. Implantation Techniques and Methods of Dose Specifications. Importance of Brachytherapy in GYN

Brachytherapy Planning and Quality Assurance

ESTRO-CARO Teaching Course on Image-guided cervix radiotherapy - With a special focus on adaptive brachytherapy Hilton Hotel Toronto Toronto, Canada

Brachytherapy an Overview

Brachytherapy Planning and Quality Assurance w Classical implant systems and modern computerized dosimetry w Most common clinical applications w

Linking DVH-parameters to clinical outcome. Richard Pötter, Medical University of Vienna, General Hospital of Vienna, Austria

Local Organiser: Madhup Rastogi, Radiation Oncologist, Ram Manohar Lohia Institute of Medical Sciences, Lucknow

Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?

Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?

MR-Guided Brachytherapy

Basic Concepts in Image Based Brachytherapy (GEC-ESTRO Target Concept & Contouring)

Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer

3D ANATOMY-BASED PLANNING OPTIMIZATION FOR HDR BRACHYTHERAPY OF CERVIX CANCER

Review of brachytherapy in

Content. Acknowledgments. Prostate brachy LDR Prostate brachy HDR. Use of permanent seeds and HDR in prostate: Current practice and advances

Recent proceedings in Brachytherapy Physics

The New ICRU/GEC ESTRO Report in Clinical Practice. Disclosures

presenting Brachytherapy with focus on Gynecological Cancers

PROSTATE CANCER BRACHYTHERAPY. Kazi S. Manir MD,DNB,PDCR RMO cum Clinical Tutor Department of Radiotherapy R. G. Kar Medical College

Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer

ICRT รศ.พญ.เยาวล กษณ ชาญศ ลป

Limitations. General Clinical Applications of Brachytherapy Physics. Learning Objectives. Conflicts of Interest. University of Wisconsin - Madison

Clinical Applications of Brachytherapy Radiobiology. Radiobiology is Essential


NIH Public Access Author Manuscript Int J Radiat Oncol Biol Phys. Author manuscript; available in PMC 2015 July 01.

Image guided brachytherapy in cervical cancer Clinical Aspects

Version A European study on MRI-guided brachytherapy in locally advanced cervical cancer EMBRACE (ENDORSED BY GEC ESTRO)

Image guided adaptive brachytherapy in patients with cervical cancer

THE IMPORTANCE OF IMMOBILIZATION AND LOCALIZATION OF GYNECOLOGICAL APPLICATORS IN HIGH DOSE RATE BRACHYTHERAPY TREATMENTS.

Brachytherapy. What is brachytherapy and how is it used?

The Evolution of RT Techniques for Gynaecological Cancers in a developing country context

GOROC POSITION PAPER ON IGBT FOR CERVICAL CANCER FACULTY OF RADIATION ONCOLOGY THE ROYAL AUSTRALIAN AND NEW ZEALAND COLLEGE OF RADIOLOGISTS

BRACHYTHERAPY IN HORSES

Interim Report. Prostate Cancer Fight Foundation Motorcycle Ride for Dad. February 7, Supporting Kingston s university hospitals:

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 6, NUMBER 2, SPRING 2005

EMBRACE 9 th Annual Meeting. Bladder toxicity: Risk factors. Sofia Spampinato, Lars Fokdal, Jacob Lindegaard, Kari Tanderup, Richard Pötter

MRI Guided GYN Brachytherapy: Clinical Considerations

Regulatory Guidelines and Computational Methods for Safe Release of Radioactive Patients II. Brachytherapy

Brachytherapy The use of radioactive sources in close proximity to the target area for radiotherapy

Patient Safety Focused QA. LDR Brachytherapy Vrinda Narayana

Recent Advances and current status of radiotherapy for cervix cancer

REVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria

HDR Brachytherapy: Results and Future Studies in Monotherapy

Basic Fundamentals & Tricks of the Trade for Intracavitary Radiotherapy for Cervix Cancer. Paula A. Berner, B.S., CMD, FAAMD

brachytherapy Medical University of Vienna, Vienna, Austria, November 2014 Educational Workshop 3-D image-guided adaptive

Chapter 13: Brachytherapy: Physical and Clinical Aspects

Sample UC Irvine Medical Dosimetry Program Official Transcript

Dosimetric comparison of interstitial brachytherapy with multi-channel vaginal cylinder plans in patients with vaginal tumors

Johannes C. Athanasios Dimopoulos

CT Guided Contouring: Challenges and Pitfalls

Number of targets 1. Number of OARs 2. Total number of plans 22. Analyzed OAR structures. Feature Min Max Mean Std

MRI Based treatment planning for with focus on prostate cancer. Xinglei Shen, MD Department of Radiation Oncology KUMC

DOSIMETRIC OPTIONS AND POSSIBILITIES OF PROSTATE LDR BRACHYTHERAPY WITH PERMANENT I-125 IMPLANTS

Calibration of TLD700:LiF for Clinical Radiotherapy Beam Modalities & Verification of a High Dose Rate Brachytherapy Treatment Planning System

Outline. Contour quality control. Dosimetric impact of contouring errors and variability in Intensity Modulated Radiation Therapy (IMRT)

Stepping source prostate brachytherapy: From target definition to dose delivery Dinkla, A.M.

Predicting Maximum Pacemaker/ICD Dose in SAVI HDR Brachytherapy

SYSTEMS IN BRACHYTHERAPY. Alfredo Polo MD, PhD Division of Human Health International Atomic Energy Agency

The Future of Brachytherapy. Alex Rijnders Europe Hospitals Brussels, Belgium

CT Guided Contouring: Challenges and Pitfalls

INTRODUCTION PATIENT. J. Radiat. Res., 52, (2011)

Advances in Image-guided Brachytherapy

Comparison of rectal and bladder ICRU point doses to the GEC ESTRO volumetric doses in Cervix cancer

Online in vivo dosimetry in conformal radiotherapies with MOSkin detectors

GYN GEC-ESTRO/ICRU 89 Target Concept. Richard Pötter Medical University Vienna

Using Task Group 137 to Prescribe and Report Dose. Vrinda Narayana. Department of Radiation Oncology University of Michigan. The

HDR Applicators and Dosimetry*

Assessment of dose homogeneity in conformal interstitial breast brachytherapy with special respect to ICRU recommendations

IMRT - the physician s eye-view. Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia

Quality management for Breast Brachytherapy.

Index. T1 and T2-weighted images, 189

Therapeutic Medical Physics. Stephen J. Amadon Jr., Ph.D., DABR

Abstract Purpose: Material and methods: Results: Conclusions: Key words: Purpose Address for correspondence:

Medical Dosimetry Graduate Certificate Program IU Graduate School & The Department of Radiation Oncology IU Simon Cancer Center

Feasibility of 4D IMRT Delivery for Hypofractionated High Dose Partial Prostate Treatments

University Medical Center Utrecht The Netherlands

Radiotherapy physics & Equipments

A Study on Dosimetry of Gynaecological Cancer and Quality Assurance of HDR Brachytherapy in BPKMCH, Nepal

Physics. Copyright 2010 Xoft, Inc.

Commissioning of brachytherapy Treatment Planning Systems

Trina Lynd, M.S. Medical Physicist Lifefirst Imaging & Oncology Cullman, AL Tri-State Alabama, Louisiana and Mississippi Spring 2016 Meeting April

Accuracy Requirements and Uncertainty Considerations in Radiation Therapy

Ritu Raj Upreti, S. Dayananda, R. L. Bhalawat*, Girish N. Bedre*, D. D. Deshpande

It s All About Margins. Maaike Milder, Ph.D. Accuray Symposium April 21 st 2018

Acknowledgements. QA Concerns in MR Brachytherapy. Learning Objectives. Traditional T&O. Traditional Summary. Dose calculation 3/7/2015

Quality Assurance of Ultrasound Imaging in Radiation Therapy. Zuofeng Li, D.Sc. Murty S. Goddu, Ph.D. Washington University St.

Evaluation of Normal Tissue Complication Probability and Risk of Second Primary Cancer in Prostate Radiotherapy

Impact of Bladder Distension on Organs at Risk in 3D Intracavitary Brachytherapy for Cervical Cancer

EMBRACE- Studien Analysen und Perspektiven

POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO MP (CLINICAL ONCOLOGY) PART I EXAMINATION - AUGUST Time : p.m p.m.

Graduate Theses and Dissertations

Advances in Gynecologic Brachytherapy

PGY-1. Resident Review Session Schedule

CURRICULUM OUTLINE FOR TRANSITIONING FROM 2-D RT TO 3-D CRT AND IMRT

University of Alberta

Outline - MRI - CT - US. - Combinations of imaging modalities for treatment planning

Transcription:

Day 1 Sunday 4 March 2018 Welcome and Summary of the course 13:00-13:20 15 introduction 13:20-13:50 30 Radioactivity Radioactivity: What we need to know Characteristics of LDR-PDR-HDR, radiobiological aspects, α/β-ratio and half time of Time dose patterns 13:50-14:20 30 repair, EQD2 concept 14:20-14:50 30 Tea break 14:50-15:20 30 Implantation rules Implantation and dosimetric rules, Paris system, ICRU 58 15:20-15:50 Applicator localization 30 and basic planning Performing CT- and MR-scans, digitizing applicator curve in TPS, visibility, numbering catheters, Dose prescription, Paris system Oesophagus 15:50-16:20 30 brachytherapy Bronchus 16:20-16:50 30 brachytherapy 1

Day 2 Monday 5 March 2018 Demonstration of prostate Discussion of participants variances 8:30-8:45 15 contouring homework 8:45-9:15 30 Isotope characteristics Different isotopes, Specific activity, HVL, energy, half life Prostate permanent GEC-ESTRO recommendations, indication, tools and requirements, performing 9:15-9:55 40 application, hazards, results Prostate temporary GEC-ESTRO recommendations, indication, tools and requirements, performing 9:55-10:25 30 application, hazards, results 10:25-10:55 30 Coffee break Automated treatment plan/ Building up a plan, peripheral positioning of sources, avoiding Volume implants - Prostate 10:55-11:25 30 high urethra and rectum dose, source separation, stranded sources vs. loose sources EK B 11:25-11:55 30 Dose calculation TG43 and limitations 11:55-12:25 30 Anal canal 12:25-13:25 60 Lunch 13:25-13:45 30 13:45-14:15 30 Keloids JG Time dose patterns 14.25-15.25 60 15:25-15:55 30 Tea break Characteristics of LDR-PDR-HDR, radiobiological aspects, a/b-ratio and half time of repair, EQD2 concept 14.15-14.22 7 Satellite lecture Company Demonstration of companies' activities Demonstration of prostate and breast applicators and material for prostate and breast 15.55-16.55 60 16.55-17.15 20 Recontouring prostate example Permanent implantation Treatment Planning on TPS (Make a treatment plan within dose constraints) 2

Day 3 Tuesday 6 March 2018 8.30-9.00 30 9.00-9.30 30 Dose distribution Breast brachytherapy Dose optimization 9.30-10.00 30 10.00-10.30 30 Coffee break 10.30-11.00 30 11.00-11.20 20 11.20-11.50 30 APBI Concept of dose distribution from radioactive sources, dose gradient, inverse square law, absorption, anisotropy Indication, tools and requirements, performing application (open wound, closed wound, after oncoplastic surgery), hazards, results Manual / Geometric / Volume / Graphical / Inverse (penalties, weight function, dwell time gradient) GEC-ESTRO recommendations, indication, techniques (multicatheter, Mamosite, SAVI), results Bladder Endometrial Postoperative: Indication, tools and requirements, performing application, hazards, result Skin cancer 11.50-12.30 40 JG 12.30-13.30 60 Lunch Uncertainties 13.30-14.00 30 All kind of uncertainties, applicator reconstruction errors, contouring uncertainties, source positioning errors, OAR movements, systematic errors, random errors, interfraction uncertainties, interapplication uncertainties, magnitude of uncertainties Definitive treatment: Indication, tools and requirements, performing application, Endometrial 14.00-14.20 20 hazards, results 14.20-14.27 7 Satellite lecture Company Demonstration of companies' activities Demonstration of gynaecological applicators and material for gynaecological 14.30-15.30 60 15.30-16.00 30 Tea break 16.00-17.00 60 Cervix implantation Treatment Planning on TPS (Make a treatment plan within dose constraints) JG JG 3

Day 4 Wednesday 7 March 2018 8.30-8.50 20 Demonstration of prostate recontouring example Demonstration of participants variances after recontouring. Demonstration of cervix Discussion of participants variances 8.50-9.05 15 contouring homework 9.05-9.35 30 Cervix Indication, tools and requirements, techniques, performing application 9.35-10.05 30 Cervix Hazards, results, complications 10.05-10.35 30 Coffee break GEC-ESTRO recommendations Concept of CTVIR and CTVHR, ICRU 89 report 10.35-11.05 30 and ICRU reporting 110.5-11.35 30 DVH How to use DVH, differential DVH, cumulative DVH, D98, D90, V100, D2cm3 JG Use of US, CT, and MR Imaging, slice thickness, MR sequences, MR distortions, Imaging 11.35-12.15 40 dose evaluation 12.15-13.15 60 Lunch 13.15-13.45 30 13.45-14.15 30 Interstitial gynaecological Planning with gynaecological applicators Vagina cancer, recurrence endometrial cancer or cervical cancer, indication, tools and requirements, performing application, hazards, results Applicator localization on CT and MR, Applicator library, Optimization 14.15-14.22 7 Satellite lecture Company Demonstration of companies' activities Demonstration of gynaecological applicators and material for gynaecological 14.25-15.25 60 15.25-15.55 30 Tea break 15.55-16.55 60 Cervix implantation Treatment Planning on TPS (Make a treatment plan within dose constraints) EK 16.55-17.15 20 Recontouring cervix example 4

Day 5 Thursday 8 March 2018 8.30-8.50 20 Demonstration of cervix recontouring example Demonstration of participants variances after recontouring. GEC-ESTRO recommendations, indication, tools and requirements, performing H & N cancer 8.50-9.20 30 application, Radiation safety \ Radiation HVL, distance, inverse square law, controlling systems of the machines, Geiger 9.20-9.50 30 protection teller, contamination, safe radioactive sources, requirements treatment rooms 9.50-10.20 20 Coffee break 10.20-10.50 30 H & N cancer Hazards, complications, results 10.50-11.10 20 Paediatrics Limb sarcomas, Sarcoma botryroides, prostate sarcoma, 11.10-11.30 20 Paediatrics RMS Orbit and H&N (AMORE) 11.30-12.10 Final remarks and certificate 40 12.15-13.15 60 Lunch / all teachers 5